Seagen
Bothell’s Biotech Blues: A Life Sciences Hub Under Pressure
A string of facility closures and workforce cuts threatens the Seattle suburb’s ambitions to become a major biotech center The signs of distress...
Curi Bio Signs 14,000 SQFT Lease at BioMed Realty’s 201 Elliott Avenue West in Seattle
BioMed Realty, a Blackstone portfolio company specializing in real estate solutions for the life science and technology sectors, has announced today the signing...
Pfizer Halts $350MM Manufacturing Facility in Everett, Lays Off 120
In a surprising move, Pfizer Inc. (NYSE: PFE), a leading global pharmaceutical company, has announced it is stopping its ambitious $350 million manufacturing...
Following Merger with East Coast Firm, Biotech Firm Decides to Locate HQ in Seattle
By The Registry Staff Clay Siegall, the co-founder and former CEO of Bothell-based biotech Seagen, is currently leading a new biotech venture through...
Seagen Plans to Develop 270,000 SQFT Biomanufacturing Facility in Everett
– New 270,000-square-foot facility in Everett, Washington, is expected to enhance scientific manufacturing capabilities and expand highly skilled workforce – BOTHELL, Wash.–Seagen Inc. (Nasdaq:...
